Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Haga Bioscience AB
AB
Active
Org 5594847864
Nobels Väg 16, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Haga Bioscience AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
SEK millions
0M
-1M
-3M
-4M
-5M
-1M
2024
-4M
-300%
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
0
0
Staff expenses
−301
−2 291
EBITDA
−540
−4 206
Depreciation & amort.
−2
−8
EBIT
−542
−4 214
Net financials
0
−1
Profit before tax
−542
−4 215
Tax
—
—
Net profit
−542
−4 215
Balance sheet
SEK thousands
Item
2024
2025
Total assets
5 469
2 918
Equity
5 233
2 767
Long-term debt
—
—
Short-term debt
237
151
Total debt
237
151
Financial ratios
5-year trend
EBITDA margin
-420622900.0%
This company
15.8%
Market median
-2662170353% vs market
2024
2025
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
2024
2025
Return on equity
-152.3%
This company
18.4%
Market median
-928% vs market
2024
2025
Net profit margin
-421514600.0%
This company
8.1%
Market median
-5203884051% vs market
2024
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-05-27 – 2024-12-31
View
PDF
More on Haga Bioscience AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
